Neurotech startup Neurovalens gets FDA clearance for noninvasive anxiety treatment
A 2019 rule change by the U.S. medical devices regulator aimed at encouraging innovations targeting insomnia and anxiety is bearing fruit: Neurovalens, a Belfast-based startup that for over a decade has been developing technology to deliver noninvasive electrical stimulation of the brain and nervous system, has just had its second head-mounted treatment device cleared by the FDA.
